US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Immuneering Corp

5.30

+0.05000.95%

Post-market: 5.24-0.0600-1.13%19:50 EDT

Volume:445.57K

Turnover:2.38M

Market Cap:342.22M

PE:-5.41

High:5.43

Open:5.31

Low:5.28

Close:5.25

52wk High:10.08

52wk Low:3.86

Shares:64.57M

Float Shares:49.21M

Volume Ratio:0.81

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.9796

EPS(LYR):-1.2729

ROE:-52.15%

ROA:-32.77%

PB:1.79

PE(LYR):-4.16

Loading ...

Overview Company News Filings

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO

Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Cencora (COR)

Immuneering says atebimetinib-chemo trial shows 17.3-month median survival in pancreatic cancer

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated With Atebimetinib Plus Chemotherapy

THOMSON REUTERS

Immuneering Corp - Only Anemia (16%) and Neutropenia (18%) Grade 3+ Adverse Events in ≥10% of Patients

THOMSON REUTERS

Immuneering Corp - Full Data From 55 Patients to Be Presented at Asco on June 1, 2026

THOMSON REUTERS

Immuneering Corp - Reports 17.3-Month Median Overall Survival as of April 24, 2026 Data Cutoff

THOMSON REUTERS

Immuneering Corp - Phase 3 Mapkeeper 301 Trial Recruiting; First Patient Dosing Expected Mid-2026

THOMSON REUTERS

Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy

Immuneering Is Maintained at Buy by Chardan Capital

Immuneering (IMRX) Gets a Buy from Chardan Capital

Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)

Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)

Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend

Immuneering Q1 FY26 net loss narrows to $13.5 million

Immuneering Q1 EPS $(0.21) Beats $(0.26) Estimate

Benzinga Earnings

Immuneering Corp - Ends Q1 2026 With $198.6 Mln in Cash and Securities; Runway Into 2029

THOMSON REUTERS

Immuneering Corporation Q1 Net Income USD -13.5 Million VS. Ibes Estimate USD -17.3 Million

THOMSON REUTERS

Press Release: Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates

Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/IMRX/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IMRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","market":"US","secType":"STK","nameCN":"Immuneering Corp","latestPrice":5.3,"timestamp":1787342400000,"preClose":5.25,"halted":0,"volume":445565,"hourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.3,"latestTime":"19:50 EDT","volume":4476,"amount":23781.1937,"timestamp":1787356218129,"change":-0.06,"changeRate":-0.011321,"amplitude":0.02},"delay":0,"changeRate":0.00952380952380949,"floatShares":49210000,"shares":64569967,"eps":-0.979559,"marketStatus":"Market Closed","change":0.05,"latestTime":"08-21 16:00:00 EDT","open":5.31,"high":5.43,"low":5.281277,"amount":2378383.19576,"amplitude":0.028328,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.979559,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":7,"adr":0,"listingDate":1627617600000,"exchange":"NASDAQ","adjPreClose":5.25,"preHourTrading":{"tag":"盘前","latestPrice":5.26,"preClose":5.25,"latestTime":"08:24 EDT","volume":2,"amount":10.51,"timestamp":1787315054622,"change":0.01,"changeRate":0.001905,"amplitude":0.001905},"postHourTrading":{"tag":"盘后","latestPrice":5.24,"preClose":5.3,"latestTime":"19:50 EDT","volume":4476,"amount":23781.1937,"timestamp":1787356218129,"change":-0.06,"changeRate":-0.011321,"amplitude":0.02},"volumeRatio":0.8110240975014792,"impliedVol":1.0673,"impliedVolPercentile":0.2691},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMRX\",,,,,undefined,":{"symbol":"IMRX","floatShares":49210000,"roa":"-32.77%","roe":"-52.15%","lyrEps":-1.27295,"volumeRatio":0.8110240975014792,"shares":64569967,"dividePrice":0,"high":5.43,"amplitude":0.028328,"preClose":5.25,"low":5.281277,"week52Low":3.86,"pbRate":"1.79","psRate":"752133.68","week52High":10.08,"institutionHeld":0,"latestPrice":5.3,"eps":-0.979559,"divideRate":0,"volume":445565,"delay":0,"ttmEps":-0.979559,"open":5.31,"prevYearClose":6.58,"prevWeekClose":5.06,"prevMonthClose":4.13,"prevQuarterClose":4.99,"fiveDayClose":5.06,"twentyDayClose":4.32,"sixtyDayClose":5.335},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMRX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2022-02-08","symbol":"IMRX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1644296400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2021-09-09","symbol":"IMRX","fiscalQuarterEnding":"2021/06","expectedEps":-1.78,"name":null,"time":"","type":"earning","dateTimestamp":1631160000000,"reportTimeType":"","actualEps":-1.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMRX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.75,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":8,"updateTime":1786075200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMRX","date":"2026-08-21","current":-5.410598,"percent":0.272652,"low":-35.76593,"twenty":-6.401892,"median":-4.246328,"eighty":-1.165266,"high":-0.544763,"avg":-5.593309,"sd":6.428055,"marketCap":339661360},"quantilePoints":[{"date":"2021-08-27","current":-32.375276,"twenty":-36.475658,"median":-34.52026,"eighty":-22.529012,"marketCap":649733882},{"date":"2021-09-03","current":-34.404807,"twenty":-36.171837,"median":-34.307584,"eighty":-25.783553,"marketCap":690464197},{"date":"2021-09-10","current":-22.010777,"twenty":-35.957946,"median":-32.776321,"eighty":-24.276106,"marketCap":538214828},{"date":"2021-09-17","current":-30.210454,"twenty":-35.824264,"median":-31.84055,"eighty":-25.184572,"marketCap":738716062},{"date":"2021-09-24","current":-29.160302,"twenty":-35.381899,"median":-31.06967,"eighty":-26.168957,"marketCap":713037379},{"date":"2021-10-01","current":-30.655974,"twenty":-34.823563,"median":-31.016632,"eighty":-26.847844,"marketCap":749610049},{"date":"2021-10-08","current":-29.393669,"twenty":-34.79613,"median":-30.963594,"eighty":-27.123376,"marketCap":718743753},{"date":"2021-10-15","current":-26.370502,"twenty":-34.757241,"median":-30.737841,"eighty":-25.579175,"marketCap":644820271},{"date":"2021-10-22","current":-27.420655,"twenty":-34.594392,"median":-30.019518,"eighty":-25.579175,"marketCap":670498954},{"date":"2021-10-29","current":-28.746605,"twenty":-34.370779,"median":-29.565885,"eighty":-25.859215,"marketCap":702921534},{"date":"2021-11-05","current":-31.674304,"twenty":-34.314876,"median":-29.74372,"eighty":-26.166836,"marketCap":774510591},{"date":"2021-11-12","current":-25.289652,"twenty":-34.283278,"median":-29.565885,"eighty":-26.166836,"marketCap":722963518},{"date":"2021-11-19","current":-22.558333,"twenty":-33.710006,"median":-28.972469,"eighty":-25.187144,"marketCap":644882421},{"date":"2021-11-26","current":-20.453131,"twenty":-32.879093,"median":-28.778428,"eighty":-24.841544,"marketCap":584700312},{"date":"2021-12-03","current":-17.576626,"twenty":-32.696112,"median":-28.497326,"eighty":-23.741458,"marketCap":502468724},{"date":"2021-12-10","current":-19.636457,"twenty":-32.324185,"median":-28.163187,"eighty":-22.296998,"marketCap":561353804},{"date":"2021-12-17","current":-19.309788,"twenty":-32.100427,"median":-27.505516,"eighty":-21.262189,"marketCap":552015201},{"date":"2021-12-23","current":-18.874241,"twenty":-32.022843,"median":-27.430931,"eighty":-20.552946,"marketCap":539564079},{"date":"2021-12-31","current":-14.887633,"twenty":-31.674304,"median":-27.177075,"eighty":-20.40776,"marketCap":425597617},{"date":"2022-01-07","current":-14.243147,"twenty":-31.658256,"median":-26.71902,"eighty":-19.482197,"marketCap":407173478},{"date":"2022-01-14","current":-11.969031,"twenty":-31.51519,"median":-26.42354,"eighty":-19.028489,"marketCap":342162587},{"date":"2022-01-21","current":-11.103578,"twenty":-31.481245,"median":-26.031059,"eighty":-18.640116,"marketCap":317421599},{"date":"2022-01-28","current":-9.206947,"twenty":-31.447301,"median":-25.379254,"eighty":-18.098783,"marketCap":263201990},{"date":"2022-02-04","current":-9.022808,"twenty":-31.303678,"median":-25.09002,"eighty":-15.312994,"marketCap":257937950},{"date":"2022-02-11","current":-8.746599,"twenty":-31.202956,"median":-24.614944,"eighty":-14.27445,"marketCap":250041890},{"date":"2022-02-18","current":-7.669387,"twenty":-31.093007,"median":-23.973184,"eighty":-13.003892,"marketCap":219247257},{"date":"2022-02-25","current":-7.227453,"twenty":-31.006024,"median":-23.297074,"eighty":-12.195522,"marketCap":206613562},{"date":"2022-03-04","current":-6.104206,"twenty":-30.912677,"median":-22.394998,"eighty":-11.324544,"marketCap":174502919},{"date":"2022-03-11","current":-5.104662,"twenty":-30.843317,"median":-21.805179,"eighty":-10.260222,"marketCap":171188670},{"date":"2022-03-18","current":-5.505799,"twenty":-30.766019,"median":-21.218553,"eighty":-9.206947,"marketCap":184641093},{"date":"2022-03-25","current":-5.702435,"twenty":-30.685675,"median":-20.552946,"eighty":-9.004394,"marketCap":191235417},{"date":"2022-04-01","current":-5.851878,"twenty":-30.388662,"median":-20.434983,"eighty":-8.728185,"marketCap":196247104},{"date":"2022-04-08","current":-5.560857,"twenty":-30.095892,"median":-19.881459,"eighty":-7.906926,"marketCap":186487503},{"date":"2022-04-14","current":-5.026008,"twenty":-29.909199,"median":-19.636457,"eighty":-7.155639,"marketCap":168550940},{"date":"2022-04-22","current":-4.632737,"twenty":-29.741472,"median":-19.332473,"eighty":-6.57376,"marketCap":155362291},{"date":"2022-04-29","current":-3.909117,"twenty":-29.600328,"median":-19.028489,"eighty":-6.236786,"marketCap":131095176},{"date":"2022-05-06","current":-3.863096,"twenty":-29.300322,"median":-18.77442,"eighty":-6.076585,"marketCap":129551818},{"date":"2022-05-13","current":-3.301241,"twenty":-29.085169,"median":-18.248113,"eighty":-5.773224,"marketCap":132718053},{"date":"2022-05-20","current":-2.868076,"twenty":-28.958498,"median":-17.902974,"eighty":-5.560857,"marketCap":115303756},{"date":"2022-05-27","current":-3.032154,"twenty":-28.873896,"median":-15.642603,"eighty":-5.43973,"marketCap":121900081},{"date":"2022-06-03","current":-3.117474,"twenty":-28.772063,"median":-15.136221,"eighty":-5.357929,"marketCap":125330170},{"date":"2022-06-10","current":-3.248736,"twenty":-28.702053,"median":-14.560786,"eighty":-5.169159,"marketCap":130607230},{"date":"2022-06-17","current":-3.019028,"twenty":-28.513237,"median":-14.243147,"eighty":-5.057469,"marketCap":121372375},{"date":"2022-06-24","current":-2.966523,"twenty":-28.470807,"median":-13.018623,"eighty":-4.797911,"marketCap":119261551},{"date":"2022-07-01","current":-3.281552,"twenty":-28.322301,"median":-12.535258,"eighty":-4.516125,"marketCap":131926495},{"date":"2022-07-08","current":-4.77794,"twenty":-28.19501,"median":-11.72965,"eighty":-4.342773,"marketCap":192084976},{"date":"2022-07-15","current":-4.764813,"twenty":-27.798285,"median":-11.342958,"eighty":-4.376588,"marketCap":191557270},{"date":"2022-07-22","current":-4.679493,"twenty":-27.596741,"median":-11.177233,"eighty":-4.47804,"marketCap":188127181},{"date":"2022-07-29","current":-4.279144,"twenty":-27.467328,"median":-9.768571,"eighty":-4.342843,"marketCap":172032149},{"date":"2022-08-05","current":-4.200386,"twenty":-27.441339,"median":-9.354258,"eighty":-4.248161,"marketCap":168865913},{"date":"2022-08-12","current":-3.583967,"twenty":-27.424765,"median":-9.206947,"eighty":-4.220076,"marketCap":156770256},{"date":"2022-08-19","current":-4.036488,"twenty":-27.284877,"median":-8.99979,"eighty":-4.217662,"marketCap":176564480},{"date":"2022-08-26","current":-3.638269,"twenty":-27.191847,"median":-8.820255,"eighty":-4.112624,"marketCap":159145562},{"date":"2022-09-02","current":-4.489009,"twenty":-26.964607,"median":-8.663737,"eighty":-4.062597,"marketCap":196358704},{"date":"2022-09-09","current":-5.351815,"twenty":-26.847844,"median":-8.102113,"eighty":-4.089364,"marketCap":234099692},{"date":"2022-09-16","current":-7.409278,"twenty":-26.701741,"median":-7.540489,"eighty":-4.110182,"marketCap":324097431},{"date":"2022-09-23","current":-6.184454,"twenty":-26.518292,"median":-7.478664,"eighty":-4.129108,"marketCap":270521064},{"date":"2022-09-30","current":-8.640135,"twenty":-26.430952,"median":-7.511849,"eighty":-4.171405,"marketCap":377937721},{"date":"2022-10-07","current":-7.753194,"twenty":-26.391717,"median":-7.604938,"eighty":-4.197576,"marketCap":339141042},{"date":"2022-10-14","current":-7.759227,"twenty":-26.166836,"median":-7.710958,"eighty":-4.204957,"marketCap":339404965},{"date":"2022-10-21","current":-7.825597,"twenty":-25.859215,"median":-7.75621,"eighty":-4.215247,"marketCap":342308118},{"date":"2022-10-28","current":-8.145379,"twenty":-25.579175,"median":-7.831631,"eighty":-4.220076,"marketCap":356296036},{"date":"2022-11-04","current":-6.226689,"twenty":-25.361334,"median":-7.837664,"eighty":-4.222148,"marketCap":272368525},{"date":"2022-11-11","current":-4.159708,"twenty":-25.187144,"median":-7.759227,"eighty":-4.222148,"marketCap":199883821},{"date":"2022-11-18","current":-3.846494,"twenty":-25.101534,"median":-7.732076,"eighty":-4.197576,"marketCap":184833124},{"date":"2022-11-25","current":-3.610209,"twenty":-25.039205,"median":-7.656988,"eighty":-4.124428,"marketCap":173479089},{"date":"2022-12-02","current":-3.25853,"twenty":-24.902263,"median":-7.535984,"eighty":-4.049542,"marketCap":156580060},{"date":"2022-12-09","current":-2.846405,"twenty":-24.654192,"median":-7.415311,"eighty":-3.946191,"marketCap":136776511},{"date":"2022-12-16","current":-2.302401,"twenty":-24.266189,"median":-7.240336,"eighty":-3.838309,"marketCap":110635827},{"date":"2022-12-23","current":-2.401311,"twenty":-24.011725,"median":-7.167608,"eighty":-3.788803,"marketCap":115388678},{"date":"2022-12-30","current":-2.665071,"twenty":-23.915253,"median":-6.893039,"eighty":-3.65307,"marketCap":128062950},{"date":"2023-01-06","current":-2.165026,"twenty":-23.683527,"median":-6.748692,"eighty":-3.620168,"marketCap":104034644},{"date":"2023-01-13","current":-2.434281,"twenty":-23.297074,"median":-6.444863,"eighty":-3.571744,"marketCap":116972962},{"date":"2023-01-20","current":-2.384826,"twenty":-23.091187,"median":-6.389597,"eighty":-3.539873,"marketCap":114596536},{"date":"2023-01-27","current":-2.445271,"twenty":-22.654609,"median":-6.277203,"eighty":-3.410189,"marketCap":117501057},{"date":"2023-02-03","current":-2.181511,"twenty":-22.296998,"median":-6.214689,"eighty":-3.365467,"marketCap":104826786},{"date":"2023-02-10","current":-2.077107,"twenty":-22.054954,"median":-6.163676,"eighty":-3.32093,"marketCap":99809886},{"date":"2023-02-17","current":-2.522201,"twenty":-21.846299,"median":-6.058171,"eighty":-3.281552,"marketCap":121197719},{"date":"2023-02-24","current":-2.577151,"twenty":-21.548222,"median":-5.985345,"eighty":-3.232985,"marketCap":123838193},{"date":"2023-03-03","current":-2.79695,"twenty":-21.290871,"median":-5.847945,"eighty":-3.116748,"marketCap":134400085},{"date":"2023-03-10","current":-3.940801,"twenty":-21.215562,"median":-5.7103,"eighty":-3.10326,"marketCap":199063900},{"date":"2023-03-17","current":-4.223408,"twenty":-20.877378,"median":-5.560857,"eighty":-3.116748,"marketCap":213339399},{"date":"2023-03-24","current":-5.427105,"twenty":-20.595727,"median":-5.505799,"eighty":-3.117474,"marketCap":274142450},{"date":"2023-03-31","current":-5.081696,"twenty":-20.542057,"median":-5.445473,"eighty":-3.164729,"marketCap":256694618},{"date":"2023-04-06","current":-4.375178,"twenty":-20.502131,"median":-5.427125,"eighty":-3.201482,"marketCap":221005871},{"date":"2023-04-14","current":-6.463332,"twenty":-20.438612,"median":-5.432339,"eighty":-3.225109,"marketCap":326485946},{"date":"2023-04-21","current":-6.832312,"twenty":-20.413204,"median":-5.498193,"eighty":-3.252654,"marketCap":345124456},{"date":"2023-04-28","current":-6.132304,"twenty":-20.19724,"median":-5.560857,"eighty":-3.267739,"marketCap":309764542},{"date":"2023-05-05","current":-4.649577,"twenty":-19.866941,"median":-5.533328,"eighty":-3.281552,"marketCap":234866707},{"date":"2023-05-11","current":-4.111377,"twenty":-19.803422,"median":-5.498193,"eighty":-3.28549,"marketCap":210590323},{"date":"2023-05-18","current":-4.945072,"twenty":-19.678198,"median":-5.458607,"eighty":-3.297303,"marketCap":253293360},{"date":"2023-05-26","current":-3.72879,"twenty":-19.513049,"median":-5.429742,"eighty":-3.311742,"marketCap":190993723},{"date":"2023-06-02","current":-5.379051,"twenty":-19.431382,"median":-5.427105,"eighty":-3.316992,"marketCap":275522339},{"date":"2023-06-07","current":-5.281977,"twenty":-19.380567,"median":-5.411414,"eighty":-3.319617,"marketCap":270550068},{"date":"2023-06-15","current":-5.321949,"twenty":-19.337011,"median":-5.419259,"eighty":-3.32093,"marketCap":272597473},{"date":"2023-06-23","current":-6.446867,"twenty":-19.309788,"median":-5.427145,"eighty":-3.32093,"marketCap":330217326},{"date":"2023-06-30","current":-5.470415,"twenty":-19.204528,"median":-5.432339,"eighty":-3.331431,"marketCap":280202124},{"date":"2023-07-07","current":-5.658853,"twenty":-19.043008,"median":-5.458607,"eighty":-3.349234,"marketCap":289854180},{"date":"2023-07-14","current":-5.413313,"twenty":-19.015785,"median":-5.464511,"eighty":-3.358014,"marketCap":277277258},{"date":"2023-07-21","current":-5.83016,"twenty":-18.946824,"median":-5.498966,"eighty":-3.361598,"marketCap":298628777},{"date":"2023-07-28","current":-5.35621,"twenty":-18.834312,"median":-5.502382,"eighty":-3.366756,"marketCap":274352393},{"date":"2023-08-04","current":-5.856075,"twenty":-18.640116,"median":-5.538938,"eighty":-3.368463,"marketCap":299956153},{"date":"2023-08-11","current":-5.640407,"twenty":-18.451374,"median":-5.556069,"eighty":-3.380171,"marketCap":292640150},{"date":"2023-08-18","current":-4.969198,"twenty":-18.244355,"median":-5.538938,"eighty":-3.402313,"marketCap":257815972},{"date":"2023-08-25","current":-5.454273,"twenty":-18.229322,"median":-5.536059,"eighty":-3.424628,"marketCap":282983025},{"date":"2023-09-01","current":-5.082007,"twenty":-18.098783,"median":-5.505799,"eighty":-3.473171,"marketCap":263668775},{"date":"2023-09-08","current":-4.732301,"twenty":-17.576626,"median":-5.490588,"eighty":-3.478329,"marketCap":245525085},{"date":"2023-09-15","current":-4.320552,"twenty":-16.848713,"median":-5.45644,"eighty":-3.500309,"marketCap":224162354},{"date":"2023-09-22","current":-4.360034,"twenty":-15.642603,"median":-5.442993,"eighty":-3.543057,"marketCap":226210835},{"date":"2023-09-29","current":-4.416439,"twenty":-15.41427,"median":-5.427145,"eighty":-3.548423,"marketCap":229137237},{"date":"2023-10-06","current":-4.207743,"twenty":-15.180414,"median":-5.412363,"eighty":-3.550464,"marketCap":218309551},{"date":"2023-10-13","current":-3.522434,"twenty":-14.937351,"median":-5.379051,"eighty":-3.550464,"marketCap":182753773},{"date":"2023-10-20","current":-3.384244,"twenty":-14.860012,"median":-5.35907,"eighty":-3.513584,"marketCap":175584090},{"date":"2023-10-27","current":-3.023258,"twenty":-14.841598,"median":-5.356356,"eighty":-3.478329,"marketCap":156855120},{"date":"2023-11-03","current":-3.384244,"twenty":-14.279974,"median":-5.34622,"eighty":-3.412814,"marketCap":175584090},{"date":"2023-11-10","current":-2.947163,"twenty":-14.252354,"median":-5.321949,"eighty":-3.384244,"marketCap":152172878},{"date":"2023-11-17","current":-2.913665,"twenty":-14.243147,"median":-5.300305,"eighty":-3.384244,"marketCap":150443281},{"date":"2023-11-24","current":-4.364829,"twenty":-13.705461,"median":-5.294869,"eighty":-3.382454,"marketCap":225372231},{"date":"2023-12-01","current":-3.718608,"twenty":-13.129106,"median":-5.237177,"eighty":-3.384244,"marketCap":192005433},{"date":"2023-12-08","current":-4.631254,"twenty":-12.974429,"median":-5.212533,"eighty":-3.384244,"marketCap":239128718},{"date":"2023-12-15","current":-4.381835,"twenty":-12.812387,"median":-5.168731,"eighty":-3.384244,"marketCap":226250305},{"date":"2023-12-22","current":-3.956689,"twenty":-12.49751,"median":-5.15972,"eighty":-3.384244,"marketCap":204298464},{"date":"2023-12-29","current":-4.421515,"twenty":-12.271019,"median":-5.151886,"eighty":-3.384244,"marketCap":228299143},{"date":"2024-01-05","current":-3.837648,"twenty":-12.044528,"median":-5.118331,"eighty":-3.384244,"marketCap":198151949},{"date":"2024-01-12","current":-3.531543,"twenty":-11.586022,"median":-5.092178,"eighty":-3.384244,"marketCap":182346623},{"date":"2024-01-19","current":-3.293462,"twenty":-11.446076,"median":-5.084468,"eighty":-3.384244,"marketCap":170053593},{"date":"2024-01-26","current":-3.514538,"twenty":-11.37242,"median":-5.081696,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-02-02","current":-3.256616,"twenty":-11.315338,"median":-5.051704,"eighty":-3.384244,"marketCap":168151100},{"date":"2024-02-09","current":-3.452183,"twenty":-11.269303,"median":-5.026008,"eighty":-3.380663,"marketCap":178248946},{"date":"2024-02-16","current":-3.797968,"twenty":-11.162502,"median":-4.979499,"eighty":-3.384244,"marketCap":196103110},{"date":"2024-02-23","current":-3.639247,"twenty":-10.897342,"median":-4.964988,"eighty":-3.384244,"marketCap":187907756},{"date":"2024-03-01","current":-3.514538,"twenty":-10.260222,"median":-4.924075,"eighty":-3.384244,"marketCap":181468550},{"date":"2024-03-08","current":-3.658244,"twenty":-9.709646,"median":-4.89778,"eighty":-3.384244,"marketCap":195612256},{"date":"2024-03-15","current":-1.58816,"twenty":-9.573383,"median":-4.876386,"eighty":-3.370913,"marketCap":84921488},{"date":"2024-03-22","current":-1.495061,"twenty":-9.38372,"median":-4.839647,"eighty":-3.363712,"marketCap":79943332},{"date":"2024-03-28","current":-1.330768,"twenty":-9.206947,"median":-4.791108,"eighty":-3.351606,"marketCap":71158350},{"date":"2024-04-05","current":-1.286957,"twenty":-9.206947,"median":-4.774314,"eighty":-3.322939,"marketCap":68815689},{"date":"2024-04-12","current":-1.139094,"twenty":-9.203264,"median":-4.742734,"eighty":-3.314805,"marketCap":60909205},{"date":"2024-04-19","current":-0.969325,"twenty":-9.160911,"median":-4.686056,"eighty":-3.281552,"marketCap":51831391},{"date":"2024-04-26","current":-0.793024,"twenty":-9.045594,"median":-4.679711,"eighty":-3.256999,"marketCap":42404297},{"date":"2024-05-03","current":-0.865117,"twenty":-9.02559,"median":-4.67293,"eighty":-3.222326,"marketCap":46259233},{"date":"2024-05-10","current":-0.853881,"twenty":-9.013601,"median":-4.631996,"eighty":-3.197538,"marketCap":46259233},{"date":"2024-05-17","current":-0.842934,"twenty":-8.960201,"median":-4.600736,"eighty":-3.119794,"marketCap":45666166},{"date":"2024-05-24","current":-0.777251,"twenty":-8.87918,"median":-4.556776,"eighty":-3.079409,"marketCap":42107764},{"date":"2024-05-31","current":-0.755356,"twenty":-8.820255,"median":-4.537707,"eighty":-3.038717,"marketCap":40921629},{"date":"2024-06-07","current":-0.771777,"twenty":-8.746599,"median":-4.512325,"eighty":-2.993026,"marketCap":41811230},{"date":"2024-06-14","current":-0.925038,"twenty":-8.709772,"median":-4.502289,"eighty":-2.980329,"marketCap":50114169},{"date":"2024-06-21","current":-0.771777,"twenty":-8.664307,"median":-4.495207,"eighty":-2.939832,"marketCap":41811230},{"date":"2024-06-28","current":-0.782724,"twenty":-8.640135,"median":-4.489009,"eighty":-2.920581,"marketCap":42404297},{"date":"2024-07-05","current":-0.618516,"twenty":-8.629554,"median":-4.472533,"eighty":-2.895554,"marketCap":33508291},{"date":"2024-07-12","current":-0.717041,"twenty":-8.545779,"median":-4.46206,"eighty":-2.873326,"marketCap":38845895},{"date":"2024-07-15","current":-0.678726,"twenty":-8.525496,"median":-4.461562,"eighty":-2.868076,"marketCap":36770160},{"date":"2024-08-02","current":-0.738935,"twenty":-8.503775,"median":-4.455922,"eighty":-2.850739,"marketCap":40032029},{"date":"2024-08-09","current":-0.592364,"twenty":-8.404824,"median":-4.42544,"eighty":-2.804643,"marketCap":33211757},{"date":"2024-08-16","current":-0.571208,"twenty":-8.326387,"median":-4.418977,"eighty":-2.748595,"marketCap":32025623},{"date":"2024-08-23","current":-0.555341,"twenty":-8.193648,"median":-4.410178,"eighty":-2.718038,"marketCap":31136022},{"date":"2024-08-30","current":-0.61352,"twenty":-8.144091,"median":-4.381439,"eighty":-2.669467,"marketCap":34397891},{"date":"2024-09-06","current":-0.629387,"twenty":-8.138941,"median":-4.377791,"eighty":-2.637596,"marketCap":35287492},{"date":"2024-09-13","current":-0.756322,"twenty":-8.109177,"median":-4.364829,"eighty":-2.553047,"marketCap":42404297},{"date":"2024-09-20","current":-1.27993,"twenty":-8.065285,"median":-4.359401,"eighty":-2.472746,"marketCap":71761119},{"date":"2024-09-27","current":-1.38042,"twenty":-8.006605,"median":-4.328077,"eighty":-2.428786,"marketCap":77395256},{"date":"2024-10-04","current":-1.253485,"twenty":-7.946269,"median":-4.308243,"eighty":-2.401311,"marketCap":70278451},{"date":"2024-10-11","current":-1.17415,"twenty":-7.940236,"median":-4.278792,"eighty":-2.379331,"marketCap":65830448},{"date":"2024-10-18","current":-1.105394,"twenty":-7.928168,"median":-4.243224,"eighty":-2.324381,"marketCap":61975511},{"date":"2024-10-25","current":-1.137127,"twenty":-7.922135,"median":-4.223408,"eighty":-2.296906,"marketCap":63754713},{"date":"2024-10-31","current":-1.015481,"twenty":-7.922135,"median":-4.220076,"eighty":-2.247451,"marketCap":56934441},{"date":"2024-11-08","current":-1.02077,"twenty":-7.917308,"median":-4.210694,"eighty":-2.203491,"marketCap":57230975},{"date":"2024-11-15","current":-0.990682,"twenty":-7.877486,"median":-4.200386,"eighty":-2.163927,"marketCap":57527508},{"date":"2024-11-22","current":-1.077494,"twenty":-7.863006,"median":-4.18227,"eighty":-2.124364,"marketCap":62568579},{"date":"2024-11-29","current":-1.117565,"twenty":-7.850938,"median":-4.154565,"eighty":-1.653919,"marketCap":64895436},{"date":"2024-12-06","current":-1.144301,"twenty":-7.836458,"median":-4.134218,"eighty":-1.535604,"marketCap":66447958},{"date":"2024-12-13","current":-1.053398,"twenty":-7.828011,"median":-4.114285,"eighty":-1.501633,"marketCap":61169382},{"date":"2024-12-20","current":-0.983885,"twenty":-7.785775,"median":-4.110253,"eighty":-1.404904,"marketCap":57132824},{"date":"2024-12-27","current":-1.16569,"twenty":-7.756814,"median":-4.094935,"eighty":-1.382465,"marketCap":67689976},{"date":"2025-01-03","current":-1.181731,"twenty":-7.753194,"median":-4.069124,"eighty":-1.319715,"marketCap":68621490},{"date":"2025-01-10","current":-1.06944,"twenty":-7.753194,"median":-4.066404,"eighty":-1.306374,"marketCap":62100896},{"date":"2025-01-17","current":-1.048051,"twenty":-7.710958,"median":-4.027437,"eighty":-1.27993,"marketCap":60858878},{"date":"2025-01-24","current":-1.149648,"twenty":-7.677701,"median":-4.004689,"eighty":-1.260248,"marketCap":66758463},{"date":"2025-01-31","current":-1.037357,"twenty":-7.649549,"median":-3.985032,"eighty":-1.226534,"marketCap":60237869},{"date":"2025-02-07","current":-1.064093,"twenty":-7.561309,"median":-3.979207,"eighty":-1.20312,"marketCap":61790391},{"date":"2025-02-14","current":-0.994579,"twenty":-7.536885,"median":-3.968026,"eighty":-1.196414,"marketCap":57753833},{"date":"2025-02-21","current":-0.914371,"twenty":-7.521503,"median":-3.9572,"eighty":-1.17549,"marketCap":53096266},{"date":"2025-02-28","current":-0.892982,"twenty":-7.492892,"median":-3.932768,"eighty":-1.164843,"marketCap":51854248},{"date":"2025-03-07","current":-0.807427,"twenty":-7.444909,"median":-3.863096,"eighty":-1.158283,"marketCap":46886176},{"date":"2025-03-14","current":-0.823469,"twenty":-7.414105,"median":-3.842071,"eighty":-1.144301,"marketCap":47817689},{"date":"2025-03-21","current":-0.882288,"twenty":-7.351355,"median":-3.83198,"eighty":-1.141087,"marketCap":51233239},{"date":"2025-03-28","current":-0.976018,"twenty":-7.269298,"median":-3.811457,"eighty":-1.130407,"marketCap":59572838},{"date":"2025-04-04","current":-0.887824,"twenty":-7.236716,"median":-3.801177,"eighty":-1.115426,"marketCap":54189750},{"date":"2025-04-11","current":-0.729074,"twenty":-7.230193,"median":-3.789261,"eighty":-1.103846,"marketCap":44500192},{"date":"2025-04-17","current":-0.734953,"twenty":-7.179577,"median":-3.774363,"eighty":-1.086551,"marketCap":44859065},{"date":"2025-04-25","current":-0.858426,"twenty":-7.067737,"median":-3.746951,"eighty":-1.070619,"marketCap":52395387},{"date":"2025-05-02","current":-0.758472,"twenty":-6.968014,"median":-3.738989,"eighty":-1.063486,"marketCap":46294555},{"date":"2025-05-09","current":-0.691313,"twenty":-6.896128,"median":-3.72879,"eighty":-1.048324,"marketCap":42705829},{"date":"2025-05-16","current":-0.74855,"twenty":-6.859478,"median":-3.718608,"eighty":-1.042704,"marketCap":46241627},{"date":"2025-05-23","current":-0.844668,"twenty":-6.802547,"median":-3.708154,"eighty":-1.037357,"marketCap":52179267},{"date":"2025-05-30","current":-0.987387,"twenty":-6.754216,"median":-3.695933,"eighty":-1.028657,"marketCap":60995764},{"date":"2025-06-06","current":-1.194185,"twenty":-6.724496,"median":-3.676093,"eighty":-1.028657,"marketCap":73770689},{"date":"2025-06-13","current":-1.141758,"twenty":-6.654128,"median":-3.658244,"eighty":-1.036781,"marketCap":70531975},{"date":"2025-06-20","current":-1.613606,"twenty":-6.612475,"median":-3.654984,"eighty":-1.037357,"marketCap":99680394},{"date":"2025-06-27","current":-1.858269,"twenty":-6.583701,"median":-3.641213,"eighty":-1.037357,"marketCap":114794389},{"date":"2025-07-03","current":-2.009726,"twenty":-6.53362,"median":-3.635252,"eighty":-1.04087,"marketCap":124150671},{"date":"2025-07-11","current":-2.522352,"twenty":-6.52094,"median":-3.620168,"eighty":-1.041748,"marketCap":155818089},{"date":"2025-07-18","current":-2.504876,"twenty":-6.474846,"median":-3.596047,"eighty":-1.042513,"marketCap":154738518},{"date":"2025-07-25","current":-2.330118,"twenty":-6.463288,"median":-3.571744,"eighty":-1.042704,"marketCap":143942808},{"date":"2025-08-01","current":-2.003901,"twenty":-6.450149,"median":-3.558444,"eighty":-1.045337,"marketCap":123790814},{"date":"2025-08-08","current":-2.044678,"twenty":-6.445264,"median":-3.543057,"eighty":-1.046971,"marketCap":126309814},{"date":"2025-08-15","current":-1.777103,"twenty":-6.421957,"median":-3.518486,"eighty":-1.047884,"marketCap":110409386},{"date":"2025-08-22","current":-2.706575,"twenty":-6.404194,"median":-3.504905,"eighty":-1.048453,"marketCap":168156400},{"date":"2025-08-29","current":-3.273611,"twenty":-6.396742,"median":-3.485096,"eighty":-1.048697,"marketCap":203385711},{"date":"2025-09-05","current":-3.653269,"twenty":-6.392011,"median":-3.496086,"eighty":-1.051532,"marketCap":226973433},{"date":"2025-09-12","current":-5.493285,"twenty":-6.383596,"median":-3.504905,"eighty":-1.056035,"marketCap":341291555},{"date":"2025-09-19","current":-6.028562,"twenty":-6.373537,"median":-3.518486,"eighty":-1.05924,"marketCap":374547736},{"date":"2025-09-26","current":-8.142907,"twenty":-6.373537,"median":-3.543057,"eighty":-1.061931,"marketCap":505909592},{"date":"2025-10-03","current":-6.646648,"twenty":-6.407203,"median":-3.558444,"eighty":-1.063689,"marketCap":412948704},{"date":"2025-10-10","current":-6.351468,"twenty":-6.407203,"median":-3.571744,"eighty":-1.06666,"marketCap":394609481},{"date":"2025-10-17","current":-5.638963,"twenty":-6.397853,"median":-3.592789,"eighty":-1.069012,"marketCap":350342392},{"date":"2025-10-24","current":-5.730571,"twenty":-6.393562,"median":-3.610209,"eighty":-1.06944,"marketCap":356033875},{"date":"2025-10-31","current":-6.524505,"twenty":-6.405727,"median":-3.627238,"eighty":-1.071208,"marketCap":405360060},{"date":"2025-11-07","current":-6.738256,"twenty":-6.453431,"median":-3.639247,"eighty":-1.073827,"marketCap":418640187},{"date":"2025-11-14","current":-6.565219,"twenty":-6.504741,"median":-3.649093,"eighty":-1.076411,"marketCap":407889608},{"date":"2025-11-21","current":-7.221924,"twenty":-6.538979,"median":-3.656253,"eighty":-1.079078,"marketCap":451344069},{"date":"2025-11-28","current":-7.914154,"twenty":-6.597041,"median":-3.661921,"eighty":-1.083812,"marketCap":494605947},{"date":"2025-12-05","current":-6.91197,"twenty":-6.657384,"median":-3.682825,"eighty":-1.092068,"marketCap":431973079},{"date":"2025-12-12","current":-6.405712,"twenty":-6.657384,"median":-3.695933,"eighty":-1.098009,"marketCap":400333795},{"date":"2025-12-19","current":-5.858127,"twenty":-6.634434,"median":-3.709906,"eighty":-1.101065,"marketCap":366111712},{"date":"2025-12-26","current":-7.035952,"twenty":-6.660962,"median":-3.718608,"eighty":-1.102297,"marketCap":439721475},{"date":"2026-01-02","current":-6.798321,"twenty":-6.738256,"median":-3.726533,"eighty":-1.105394,"marketCap":424870382},{"date":"2026-01-09","current":-4.886939,"twenty":-6.757899,"median":-3.736695,"eighty":-1.106806,"marketCap":305415943},{"date":"2026-01-16","current":-4.793953,"twenty":-6.739485,"median":-3.744117,"eighty":-1.10687,"marketCap":299604646},{"date":"2026-01-23","current":-5.517178,"twenty":-6.738502,"median":-3.771529,"eighty":-1.111148,"marketCap":344803623},{"date":"2026-01-30","current":-5.031584,"twenty":-6.738256,"median":-3.780554,"eighty":-1.112218,"marketCap":314455739},{"date":"2026-02-06","current":-4.669971,"twenty":-6.736715,"median":-3.799573,"eighty":-1.116496,"marketCap":291856250},{"date":"2026-02-13","current":-5.12457,"twenty":-6.689013,"median":-3.803637,"eighty":-1.117565,"marketCap":320267036},{"date":"2026-02-20","current":-5.424192,"twenty":-6.669598,"median":-3.819277,"eighty":-1.120773,"marketCap":338992326},{"date":"2026-02-27","current":-5.155565,"twenty":-6.653805,"median":-3.83525,"eighty":-1.12612,"marketCap":322204135},{"date":"2026-03-06","current":-5.145234,"twenty":-6.628326,"median":-3.860323,"eighty":-1.130407,"marketCap":321558435},{"date":"2026-03-13","current":-6.289319,"twenty":-6.61393,"median":-3.916926,"eighty":-1.132899,"marketCap":352358446},{"date":"2026-03-20","current":-5.608457,"twenty":-6.612399,"median":-3.956689,"eighty":-1.135719,"marketCap":314213220},{"date":"2026-03-27","current":-6.023898,"twenty":-6.6085,"median":-3.966616,"eighty":-1.138307,"marketCap":337488273},{"date":"2026-04-02","current":-6.150838,"twenty":-6.597041,"median":-3.973199,"eighty":-1.14016,"marketCap":344600095},{"date":"2026-04-10","current":-6.53166,"twenty":-6.576308,"median":-3.981126,"eighty":-1.141758,"marketCap":365935561},{"date":"2026-04-17","current":-6.427799,"twenty":-6.581349,"median":-3.986625,"eighty":-1.141758,"marketCap":360116797},{"date":"2026-04-24","current":-7.078888,"twenty":-6.597041,"median":-4.01597,"eighty":-1.142021,"marketCap":396594001},{"date":"2026-05-01","current":-6.051122,"twenty":-6.609782,"median":-4.04597,"eighty":-1.142416,"marketCap":339013469},{"date":"2026-05-08","current":-6.028026,"twenty":-6.597041,"median":-4.066733,"eighty":-1.14317,"marketCap":337719524},{"date":"2026-05-15","current":-5.935642,"twenty":-6.581349,"median":-4.091001,"eighty":-1.144301,"marketCap":332543746},{"date":"2026-05-22","current":-6.203557,"twenty":-6.57278,"median":-4.110253,"eighty":-1.144301,"marketCap":337719524},{"date":"2026-05-29","current":-6.013426,"twenty":-6.564313,"median":-4.113505,"eighty":-1.14537,"marketCap":327368854},{"date":"2026-06-05","current":-5.32414,"twenty":-6.564313,"median":-4.129095,"eighty":-1.149728,"marketCap":289844360},{"date":"2026-06-12","current":-4.896307,"twenty":-6.554883,"median":-4.149422,"eighty":-1.151694,"marketCap":266553296},{"date":"2026-06-18","current":-5.24095,"twenty":-6.53166,"median":-4.177765,"eighty":-1.158283,"marketCap":285315542},{"date":"2026-06-26","current":-5.383561,"twenty":-6.524505,"median":-4.196874,"eighty":-1.158283,"marketCap":293079231},{"date":"2026-07-02","current":-6.001541,"twenty":-6.524505,"median":-4.207873,"eighty":-1.15993,"marketCap":326721880},{"date":"2026-07-10","current":-6.369953,"twenty":-6.524505,"median":-4.219024,"eighty":-1.160868,"marketCap":346778074},{"date":"2026-07-17","current":-5.680667,"twenty":-6.521781,"median":-4.221742,"eighty":-1.163058,"marketCap":309253581},{"date":"2026-07-24","current":-5.217182,"twenty":-6.52094,"median":-4.24012,"eighty":-1.165266,"marketCap":284021594},{"date":"2026-07-31","current":-5.027034,"twenty":-6.487193,"median":-4.246328,"eighty":-1.165266,"marketCap":273670010},{"date":"2026-08-07","current":-5.037876,"twenty":-6.450287,"median":-4.246328,"eighty":-1.165266,"marketCap":288550412},{"date":"2026-08-14","current":-5.873756,"twenty":-6.416237,"median":-4.246328,"eighty":-1.165266,"marketCap":336426490},{"date":"2026-08-21","current":-5.930235,"twenty":-6.401892,"median":-4.246328,"eighty":-1.165266,"marketCap":339661360}],"updateTime":1787422392295},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IMRX\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2640804959","title":"Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Cancer Patients at ASCO","url":"https://stock-news.laohu8.com/highlight/detail?id=2640804959","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640804959?lang=en_us&edition=fundamental","pubTime":"2026-06-01 19:30","pubTimestamp":1780313400,"startTime":"0","endTime":"0","summary":"- 17.3 months median overall survival in 55 first-line pancreatic cancer patients; vs. 8.5 months for standard of care chemotherapy in the pivotal MPACT study - - Only two categories of Grade 3+ treat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304230/0/en/Immuneering-Presents-Compelling-17-3-Month-Median-Overall-Survival-and-Favorable-Tolerability-with-Atebimetinib-Chemotherapy-in-First-Line-Pancreatic-Cancer-Patients-at-ASCO.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ORR","BK4139","IMRX","BK4563","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637365292","title":"Analysts Offer Insights on Healthcare Companies: Immuneering (IMRX) and Cencora (COR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637365292","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637365292?lang=en_us&edition=fundamental","pubTime":"2026-05-22 08:40","pubTimestamp":1779410407,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Immuneering (IMRX) and Cencora (COR). Immuneering (IMRX) In a rep...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-immuneering-imrx-and-cencora-cor-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","IMRX","LU1261432733.SGD","LU1585245621.USD","LU2237957902.USD","LU1814569148.SGD","BK4084","LU0058720904.USD","SG9999004303.SGD","XBI","LU0289739699.SGD","BK4581","BK4539","LU0029874061.USD","COR","HCSG","BK4563","BK4175","BK4137","BK4585","SGXZ23171101.USD","BK4139","LU2324357040.USD","LU0128526141.USD","LU2237957811.SGD","LU1084165304.USD","XLV","LU1119994496.HKD","LU1430594728.SGD","BK4529","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637352099","title":"Immuneering says atebimetinib-chemo trial shows 17.3-month median survival in pancreatic cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2637352099","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637352099?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:02","pubTimestamp":1779397368,"startTime":"0","endTime":"0","summary":"Immuneering reported updated Phase 2a results for atebimetinib with chemotherapy in first-line metastatic pancreatic cancer, with full data slated for an oral presentation at the ASCO Annual Meeting on June 1, 2026.The update pointed to longer survival with manageable tolerability, with severe treatment-related side effects largely attributed to chemotherapy rather than the investigational drug.The readout supports the company’s planned randomized Phase 3 MAPKeeper 301 trial, which is recruiting with a first patient dosing targeted for mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content used to generate this news brief on May 21, 2026, and is solely responsible for the informa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL8m1NqH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","BK4539","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637527563","title":"Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated With Atebimetinib Plus Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2637527563","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637527563?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4563","IMRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637369357","title":"Immuneering Corp - Only Anemia (16%) and Neutropenia (18%) Grade 3+ Adverse Events in ≥10% of Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2637369357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637369357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4539","BK4139","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357380","title":"Immuneering Corp - Full Data From 55 Patients to Be Presented at Asco on June 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357380","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357380?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4563","IMRX","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357336","title":"Immuneering Corp - Reports 17.3-Month Median Overall Survival as of April 24, 2026 Data Cutoff","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357336","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357336?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4563","IMRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637338357","title":"Immuneering Corp - Phase 3 Mapkeeper 301 Trial Recruiting; First Patient Dosing Expected Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2637338357","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637338357?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA2BPV9:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357537","title":"Immuneering Reports 17.3 Months Median Overall Survival in First-Line Metastatic Pancreatic Cancer Patients Treated with Atebimetinib Plus Chemotherapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357537","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357537?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:00","pubTimestamp":1779397200,"startTime":"0","endTime":"0","summary":"- Detailed data from 55 patients to be shared in an oral presentation at the ASCO Annual Meeting on June 1, 2026 - - Tolerability profile consistent with prior updates: only two categories of Grade 3 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/21/3299784/0/en/Immuneering-Reports-17-3-Months-Median-Overall-Survival-in-First-Line-Metastatic-Pancreatic-Cancer-Patients-Treated-with-Atebimetinib-Plus-Chemotherapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX","PFS","BK4211","BK4195","BK4539","BK4563","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636862673","title":"Immuneering Is Maintained at Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636862673","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636862673?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:45","pubTimestamp":1779223500,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/IMRX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  May 19, 2026 16:45 ET (20:45 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636886230","title":"Immuneering (IMRX) Gets a Buy from Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2636886230","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636886230?lang=en_us&edition=fundamental","pubTime":"2026-05-20 04:35","pubTimestamp":1779222952,"startTime":"0","endTime":"0","summary":"Chardan Capital analyst Geulah Livshits reiterated a Buy rating on Immuneering today and set a price target of $20.00. Livshits covers the Healthca...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/immuneering-imrx-gets-a-buy-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/immuneering-imrx-gets-a-buy-from-chardan-capital-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4563","IMRX","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636271480","title":"Mizuho Securities Sticks to Their Buy Rating for Immuneering (IMRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2636271480","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636271480?lang=en_us&edition=fundamental","pubTime":"2026-05-18 18:55","pubTimestamp":1779101740,"startTime":"0","endTime":"0","summary":"In a report released today, Graig Suvannavejh from Mizuho Securities reiterated a Buy rating on Immuneering, with a price target of $12.00. Accordi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-immuneering-imrx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-immuneering-imrx-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IMRX","MFG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635031162","title":"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Galectin Therapeutics (GALT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635031162","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635031162?lang=en_us&edition=fundamental","pubTime":"2026-05-16 01:30","pubTimestamp":1778866254,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Immuneering (IMRX), Galectin Therapeutics (GALT) and...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-galectin-therapeutics-galt-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","LU0128526141.USD","BK4539","BK4563","BK4112","BK4139","GALT","BLSG","BK4137","BK4581","XBI","LABU","BK4588","IMRX","BLSX","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635080089","title":"Immuneering posts smaller-than-expected Q1 net loss on lower R&D spend","url":"https://stock-news.laohu8.com/highlight/detail?id=2635080089","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635080089?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:43","pubTimestamp":1778845424,"startTime":"0","endTime":"0","summary":"Immuneering posts smaller-than-expected Q1 net loss on lower R&D spendOverviewUS oncology drug developer's Q1 EPS and net loss both beat analyst expectationsCompany ended Q1 with $198.6 mln in cash, c","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nL1N41S0HW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1585245621.USD","BK4175","LU0965509101.SGD","LU0314106906.USD","LU0689626769.HKD","LU1037948541.HKD","LU1061106388.HKD","LU1037948897.HKD","BK4563","LU1506573853.SGD","LU1430594728.SGD","MCK","BK4533","LU0203345920.USD","LU0203347892.USD","BK4588","LU0251142724.SGD","LU0942090050.USD","LU1934455194.USD","LU1983260115.SGD","LU0965509283.SGD","LU2468319806.SGD","LU0251131958.USD","LU1934455863.HKD","LU0122379950.USD","LU0124676726.USD","LU0432979614.USD","BK4585","LU0868494617.USD","LU0965509010.AUD","LU1366192091.USD","IMRX","LU1934455277.USD","BK4139","LU2112291526.USD","LU0048573561.USD","LU0861579265.USD","LU1023059063.AUD","LU0965508806.USD","LU0868494708.USD","BK4539","LU1057294990.SGD","LU1814569148.SGD","LU0742534661.SGD","LU2089984988.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635892860","title":"Immuneering Q1 FY26 net loss narrows to $13.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635892860","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635892860?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:39","pubTimestamp":1778845193,"startTime":"0","endTime":"0","summary":"Immuneering posted a net loss attributable to common stockholders of USD 13.5 million, or USD 0.21 per share, for Q1 2026, narrowing from a loss of USD 15 million, or USD 0.42 per share, a year earlier.R&D expense slipped 7.2% to USD 10.6 million, while G&A costs rose 16.8% to USD 4.7 million.Cash, cash equivalents and marketable securities totaled USD 198.6 million at March 31, down from USD 217 million at Dec. 31, with runway expected into 2029.Phase 3 MAPKeeper 301 trial of atebimetinib with modified gemcitabine/nab-paclitaxel in first-line metastatic pancreatic cancer is recruiting, with first patient dosing on track for mid-2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immuneering Corporation published the original content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9qqtyn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4563","BK4539","IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089408","title":"Immuneering Q1 EPS $(0.21) Beats $(0.26) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089408","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089408?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:38","pubTimestamp":1778845129,"startTime":"0","endTime":"0","summary":"Immuneering (NASDAQ:IMRX) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.26) by 19.23 percent. This is a 50 percent increase over losses of $(0.42) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52592502/immuneering-q1-eps-0-21-beats-0-26-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IMRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635089458","title":"Immuneering Corp - Ends Q1 2026 With $198.6 Mln in Cash and Securities; Runway Into 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2635089458","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635089458?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:35","pubTimestamp":1778844900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nTUAVCTLW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","BK4139","IMRX","BK4563"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635408943","title":"Immuneering Corporation Q1 Net Income USD -13.5 Million VS. Ibes Estimate USD -17.3 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635408943","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635408943?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:35","pubTimestamp":1778844900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nPLX7614E4:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IMRX","BK4563","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635894360","title":"Press Release: Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635894360","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635894360?lang=en_us&edition=fundamental","pubTime":"2026-05-15 19:35","pubTimestamp":1778844900,"startTime":"0","endTime":"0","summary":"- New survival data from Phase 2a clinical trial evaluating atebimetinib + mGnP in first-line metastatic pancreatic cancer to be presented in an oral session at 2026 ASCO Annual Meeting -. - Pivotal Phase 3 MAPKeeper 301 trial of atebimetinib + mGnP in first-line metastatic pancreatic cancer now recruiting , with first patient dosing on track for mid-2026 -. - 27 months progression-free survival to date in a third-line pancreatic cancer patient receiving atebimetinib monotherapy, with an ongoing 85% reduction in tumor burden --. cancer  is now recruiting patients across multiple clinical","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","BK4539","BK4563","IMRX","BK4139","R"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633341122","title":"Immuneering’s Phase 3 Pancreatic Cancer Trial Puts Atebimetinib in the Spotlight for IMRX Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2633341122","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2633341122?lang=en_us&edition=fundamental","pubTime":"2026-05-08 00:31","pubTimestamp":1778171514,"startTime":"0","endTime":"0","summary":"Immuneering Corp. Class A ($IMRX) announced an update on their ongoing clinical study. The Phase 3 MAPKeeper 301 study tests Immuneering Corp.’s dr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/immuneerings-phase-3-pancreatic-cancer-trial-puts-atebimetinib-in-the-spotlight-for-imrx-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/immuneerings-phase-3-pancreatic-cancer-trial-puts-atebimetinib-in-the-spotlight-for-imrx-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4211","ISBC","BK4539","BK4563","IMRX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":88,"code":"91000000","status":"200"}]}}